Xf. Zhou et al., Quantification of cellular acid sphingomyelinase and galactocerebroside beta-galactosidase activities by electrospray ionization mass spectrometry, CLIN CHEM, 47(5), 2001, pp. 874-881
Background: Diagnosis of Niemann-Pick (A and B) and Krabbe diseases is achi
eved hv measurement of the lysosomal enzymes acid sphingomyelinase (ASR-I)
and galactocerebroside beta -galactosidase (GCG), respectively. Conventiona
l assays use radiolabeled or fluorescent substrates and do not allow simult
aneous determination of two or more enzymes in the sample.
Methods: We developed a sensitive and specific method to assay ASM and GCG
in skin fibroblast homogenates using biotinylated substrate conjugates. The
products were purified by bioaffinity capture on streptavidinagarose beads
and, following release, were analyzed by electrospray ionization mass spec
trometry. Quantification was achieved using stable-isotope-labeled internal
standards that were chemically identical to the products of the enzymatic
reactions.
Results: The method demonstrated excellent linearity of ASM and GCG enzymat
ic product formation with the amount of cellular protein and incubation tim
e. The range of ASM activities in fibroblast lysates from six healthy patie
nts was 39-70 nmol.mg(-1).h(-1) compared with 3.7-5.1 nmol.mg(-1).h(-1) in
cell lysates from two patients affected with Niemann-Pick A disease. The GC
G activities toward the corresponding substrate conjugate were 4.0-6.8 nmol
.mg(-1).h(-1) in cell lysates from healthy patients compared with 0.1-0.2 n
mol.mg(-1).h(-1) in cell lysates from two patients affected with Krabbe dis
ease. The amounts of substrate conjugates needed per analysis were 15 nmol
(14 mug) for both ASM and GCG.
Conclusions: Electrospray mass spectrometry combined with the use of biotin
ylated substrate conjugates and bioaffinity purification represents a new a
pproach for the diagnosis of lysosomal storage disease as demonstrated for
Niemann-Pick A and Krabbe diseases, No radioactive substrates are used, and
the method uses a single instrumental platform to determine both ASM and G
CG in one cell sample, (C) 2001 American Association for Clinical Chemistry
.